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816-1 Screening Stress Myocardial Perfusion Imaging for Risk 
Stratification in Asymptomatic Diabetic Men
Brian G. Abbott, James A. Arrighi, Yale University School of Medicine, New Haven, CT, 
VA Connecticut Healthcare System, West Haven, CT
Background: The utility of screening asymptomatic diabetic patients for coronary artery
disease (CAD) has not been defined. The objective of the current study was to evaluate
the impact of a strategy employing screening stress myocardial perfusion imaging (MPI)
on short-term prognosis in diabetic patients without symptoms or known CAD, who other-
wise had no indication for stress MPI. Methods: Asymptomatic diabetic males were
enrolled in a strategy of screening stress MPI. All patients underwent routine MPI after
exercise or dipyridamole stress using standard protocols, and were followed clinically for
cardiac events (cardiac death, myocardial infarction, coronary angiography and revascu-
larization). The Framingham global risk assessment score was used to for comparison of
risk factors and to estimate the pre-test likelihood of CAD among patients. Results: In 44
asymptomatic diabetic males (age 66±8 years) without known CAD, 20 (45%) had an
abnormal stress MPI (9 mildly abnormal, 11 moderately/severely abnormal). During
short-term follow-up (18+3 months), there were no major adverse cardiac events in 33
patients with a normal or mildly abnormal stress MPI. Of 11 patients with a moderately/
severely abnormal MPI, 7 were subsequently referred for coronary angiography. All 7 had
significant CAD (6 with left main coronary artery and/or 3-vessel CAD), and 5 of these
patients required revascularization (4 surgical). The Framingham global risk profile score
for CAD in patients with a normal/ mildly abnormal MPI was similar to those with a mod-
erate/severely abnormal stress MPI (9.7±2.6 vs. 9.8±2.2, respectively, p=NS). Conclu-
sion: A strategy of screening asymptomatic diabetics for CAD with stress MPI may be
justified for additional risk stratification beyond clinical assessment. Patients with a nor-
mal or mildly abnormal stress MPI have a favorable prognosis, while those with a moder-
ately/severely abnormal study (25% in this population) have a high incidence of severe
CAD that may warrant assessment with angiography.
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816-2 Risk Stratification of Diabetic Patients With Rest/Stress 
ECG-Gated Tc-99m Sestamibi SPECT Imaging: 
Significance of Mild Perfusion Abnormalities
Sachin M. Navare, Gavin L. Noble, Safi U. Ahmed, Alan W. Ahlberg, Deborah M. Katten, 
Lori L. Alexander, Leslee J. Shaw, William E. Boden, Gary V. Heller, Hartford Hospital, 
Hartford, CT
Background
Diabetic patients have a higher risk for future cardiac events than comparable non-dia-
betic patients. However, there are limited data comparing severity of perfusion abnormal-
ities between diabetic and non-diabetic patients.
Methods
Consecutive patients referred for rest/stress Tc-99m sestamibi ECG-gated SPECT imag-
ing were followed (29 ± 17 months) prospectively for cardiac events (cardiac death or
myocardial infarction). Perfusion images were classified as normal [summed stress
scores (SSS) = 0-2}], mildly abnormal [SSS = 3-5] and moderate/severely abnormal
[SSS >5] by an 8-segment model. Of 8142 patients, 1865 were diabetics (23 %).
Results
Patients with diabetes had significantly higher annual cardiac event rates with both nor-
mal (2.6 % vs. 1.3 %, p<0.01) and abnormal (9.5 % vs. 4.9 %, p< 0.01) perfusion images
as compared to patients without diabetes. In non-diabetic patients, cardiac event free
survival correlated with the severity of perfusion abnormality. In diabetic patients, even
mild perfusion abnormality was associated with significantly lower event free survival.
However, assessment of LV function by gated-SPECT aided further risk stratification of
this subgroup. Patients with mild defects and normal function had an intermediate prog-
nosis while those with impaired function had worse prognosis.
Conclusion
Diabetic patients with mild perfusion abnormalities have a worse prognosis than non-dia-
betic patients. This may have implications for therapeutic approaches.
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816-3 Interaction of Age and Gender on Risk Stratification of 
Diabetic Patients With Rest/Stress ECG-Gated Tc-99m 
Sestamibi SPECT Imaging
Sachin M. Navare, Safi U. Ahmed, Gavin L. Noble, Alan W. Ahlberg, Deborah M. Katten, 
Giselle Cyr, Leslee J. Shaw, William E. Boden, Gary V. Heller, Hartford Hospital, Hartford, 
CT
Background
Diabetes is a powerful risk factor for CAD, particularly in women. However, there are lim-
ited data on the interaction of age, gender and diabetic status on risk stratification using
myocardial perfusion imaging.
Methods
Consecutive patients referred for rest/stress Tc-99m sestamibi ECG-gated SPECT imag-
ing were followed prospectively (29 ± 17 months) for cardiac events (cardiac death or
myocardial infarction). Perfusion images were classified as normal [summed stress
scores (SSS) < 3}] or abnormal [SSS > 3] by an 8-segment model. Of 1865 diabetic
patients, 884 (47%) were men and 981 (53%) were women.
Results
Annual cardiac event rates were significantly lower in women as compared with men (2.9
% vs. 4.8 %, p < 0.01). Cardiac event rates increased significantly with age (>55 years) in
women (1.2 % vs. 3.6 %, p < 0.01), not in men (3.7 % vs. 5.2 %, p = ns). Risk stratifica-
tion with perfusion imaging demonstrated that women > 55 years had outcomes similar to
non-diabetic patients (p = ns). Normal perfusion in older women was associated with low
risk (p = ns compared to younger women), while abnormal imaging was associated with
the highest risk (comparable to diabetic men, p = ns). However, men with normal perfu-
sion had intermediate risk, irrespective of age.
Conclusion
Increasing age has a significant impact on prognosis of diabetic women, but not men.
Although the risk of cardiac events in older women increased significantly, myocardial
perfusion imaging is effective in risk stratifying women diabetics.
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816-4 Effect of Glucose Lowering on Coronary Circulatory 
Dysfunction in Type 2 Diabetes Mellitus
Alvaro D. Facta, John O. Prior, Thomas H. Schindler, Jerson Cadenas, Manuel J. 
Quinones, Willa A. Hsueh, Heinrich R. Schelbert, David Geffen School of Medicine at 
UCLA, Los Angeles, CA
Objective: To determine the effect of plasma glucose lowering on coronary circulatory
function in patients with type 2 diabetes.
Methods: In sixteen type 2 diabetic patients (age 55±6 years old) with elevated fasting
glucose plasma levels myocardial blood flow (MBF) was measured with 13N-ammonia
and PET at rest, during cold pressor testing (CPT) and during adenosine hyperemia; at
baseline and after 12 weeks of glucose-lowering therapy with Glyburide and Metformin.
MBF response to adenosine represented the total vasodilator capacity and to CPT the
flow-mediated (endothelial-dependent) vasomotion.
Results: In eleven patients, plasma glucose decreased from 206±89 to 109±15 mg/dl
(p<0.01) over the follow-up period (Group 1), while in 5 patients remain elevated 241±33
and 211±35 mg/dl (p=NS; Group 2).
In Group 2, MBF at rest was 0.69±0.19 ml/g/min at baseline and 0.65±0.22 ml/g/min dur-
ing the follow up (p=NS). Adenosine hyperemic MBF was at baseline 1.38±0.11 ml/g/min
and 1.64±0.37 ml/g/min at follow-up (p=NS). During CPT, the rate pressor product (RPP)
increased by 38±12% at baseline and 36±11% at follow-up (p=NS), and MBF by only
15±22% and 22±10% at baseline and follow-up, respectively (p=NS).
In the Group 1 patients, MBF at rest was 0.78±0.24 ml/g/min at baseline and 0.67±0.12
ml/g/min at follow-up (p=NS) and these were similar to Group 2. Hyperemic MBF was
1.85±0.30 ml/g/min at baseline and did no increase significantly at follow-up, 2.05±0.51
ml/g/min (p=NS). Importantly, for RPP increases of 21±13 and 28±16% (p=NS) by CPT,
the MBF significantly increased from 10±11% at baseline to 33±18% at follow-up
(p<0.01). Moreover, the percent of improvement in the MBF response to CPT from base-
line to follow-up was significantly correlated with the percent decrease in plasma glucose
